Volumetric Measurements in Lung Cancer Screening Reduces Unnecessary Low-Dose Computed Tomography Scans: Results from a Single-Center Prospective Trial on 4119 Subjects

Gianluca Milanese, Federica Sabia, Roberta Eufrasia Ledda, Stefano Sestini, Alfonso Vittorio Marchianò, Nicola Sverzellati, Ugo Pastorino, Gianluca Milanese, Federica Sabia, Roberta Eufrasia Ledda, Stefano Sestini, Alfonso Vittorio Marchianò, Nicola Sverzellati, Ugo Pastorino

Abstract

This study aims to compare the low-dose computed tomography (LDCT) outcome and volume-doubling time (VDT) derived from the measured volume (MV) and estimated volume (EV) of pulmonary nodules (PNs) detected in a single-center lung cancer screening trial. MV, EV and VDT were obtained for prevalent pulmonary nodules detected at the baseline round of the bioMILD trial. The LDCT outcome (based on bioMILD thresholds) and VDT categories were simulated on PN- and screenee-based analyses. A weighted Cohen's kappa test was used to assess the agreement between diagnostic categories as per MV and EV, and 1583 screenees displayed 2715 pulmonary nodules. In the PN-based analysis, 40.1% PNs were included in different LDCT categories when measured by MV or EV. The agreements between MV and EV were moderate (κ = 0.49) and fair (κ = 0.37) for the LDCT outcome and VDT categories, respectively. In the screenee-based analysis, 46% pulmonary nodules were included in different LDCT categories when measured by MV or EV. The agreements between MV and EV were moderate (κ = 0.52) and fair (κ = 0.34) for the LDCT outcome and VDT categories, respectively. Within a simulated lung cancer screening based on a recommendation by estimated volumetry, the number of LDCTs performed for the evaluation of pulmonary nodules was higher compared with in prospective volumetric management.

Keywords: lung cancer screening; pulmonary nodules; semi-automated volumetry.

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
(A) Box plot of measured volume and estimated volume for dominant pulmonary nodules, with the volumetric thresholds for negative and positive LDCT outcome highlighted. Only dominant pulmonary nodules with volumes ranging from 3 to 500 mm3 are reported. (B) Box plot of measured volume VDT and estimated volume VDT for dominant pulmonary nodules. Only dominant pulmonary nodules with VDT within −1000 and 1000 are reported. (Color version online only).

References

    1. National Lung Screening Trial Research Team. Aberle D.R., Adams A.M. Reduced lung-cancer mortality with low-dose computed tomographic screening. N. Engl. J. Med. 2011;365:395–409.
    1. de Koning H.J., van der Aalst C.M., de Jong P.A. Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial. N. Engl. J. Med. 2020;382:503–513. doi: 10.1056/NEJMoa1911793.
    1. Pastorino U., Silva M., Sestini S. Prolonged lung cancer screening reduced 10-year mortality in the MILD trial: New confirmation of lung cancer screening efficacy. Ann. Oncol. 2019;30:1672. doi: 10.1093/annonc/mdz169.
    1. Ko J.P., Berman E.J., Kaur M. Pulmonary Nodules: Growth rate assessment in patients by using serial CT and three-dimensional volumetry. Radiology. 2012;262:662–671. doi: 10.1148/radiol.11100878.
    1. Kauczor H.U., Baird A.M., Blum T.G. ESR/ERS statement paper on lung cancer screening. Eur. Radiol. 2020;30:3277–3294. doi: 10.1007/s00330-020-06727-7.
    1. ACR Lung CT Screening Reporting & Data System (Lung-RADS) [(accessed on 5 January 2022)]. Available online: .
    1. Han D., Heuvelmans M.A., Oudkerk M. Volume versus diameter assessment of small pulmonary nodules in CT lung cancer screening. Transl. Lung Cancer Res. 2017;6:52–61. doi: 10.21037/tlcr.2017.01.05.
    1. Revel M.P., Bissery A., Bienvenu M. Are two-dimensional CT measurements of small noncalcified pulmonary nodules reliable? Radiology. 2004;231:453–458. doi: 10.1148/radiol.2312030167.
    1. de Margerie-Mellon C., Heidinger B.H., Bankier A.A. 2D or 3D measurements of pulmonary nodules: Preliminary answers and more open questions. J. Thorac. Dis. 2018;10:547–549. doi: 10.21037/jtd.2018.01.67.
    1. Devaraj A., van Ginneken B., Nair A. Use of Volumetry for Lung Nodule Management: Theory and Practice. Radiology. 2017;284:630–644. doi: 10.1148/radiol.2017151022.
    1. MacMahon H., Naidich D.P., Goo J.M. Guidelines for Management of Incidental Pulmonary Nodules Detected on CT Images: From the Fleischner Society 2017. Radiology. 2017;284:228–243. doi: 10.1148/radiol.2017161659.
    1. Callister M.E., Baldwin D.R., Akram A.R. British Thoracic Society guidelines for the investigation and management of pulmonary nodules. Thorax. 2015;70((Suppl. 2)):ii1–ii54. doi: 10.1136/thoraxjnl-2015-207168.
    1. Silva M., Milanese G., Sestini S. Lung cancer screening by nodule volume in Lung-RADS v1.1: Negative baseline CT yields potential for increased screening interval. Eur. Radiol. 2020;31:1956–1968. doi: 10.1007/s00330-020-07275-w.
    1. Heuvelmans M.A., Walter J.E., Vliegenthart R. Disagreement of diameter and volume measurements for pulmonary nodule size estimation in CT lung cancer screening. Thorax. 2018;73:779–781. doi: 10.1136/thoraxjnl-2017-210770.
    1. Horeweg N., van Rosmalen J., Heuvelmans M.A. Lung cancer probability in patients with CT-detected pulmonary nodules: A prespecified analysis of data from the NELSON trial of low-dose CT screening. Lancet. Oncol. 2014;15:1332–1341. doi: 10.1016/S1470-2045(14)70389-4.
    1. Mets O.M., de Jong P.A., Chung K. Fleischner recommendations for the management of subsolid pulmonary nodules: High awareness but limited conformance—a survey study. Eur. Radiol. 2016;26:3840–3849. doi: 10.1007/s00330-016-4249-y.
    1. Xie X., Willemink M.J., de Jong P.A. Small irregular pulmonary nodules in low-dose CT: Observer detection sensitivity and volumetry accuracy. AJR Am. J. Roentgenol. 2014;202:W202–W209. doi: 10.2214/AJR.13.10830.
    1. Milanese G., Eberhard M., Martini K. Vessel suppressed chest Computed Tomography for semi-automated volumetric measurements of solid pulmonary nodules. Eur. J. Radiol. 2018;101:97–102. doi: 10.1016/j.ejrad.2018.02.020.
    1. Silva M., Milanese G., Seletti V. Pulmonary quantitative CT imaging in focal and diffuse disease: Current research and clinical applications. Br. J. Radiol. 2018;2018:20170644. doi: 10.1259/bjr.20170644.

Source: PubMed

3
구독하다